A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease

clinical trial

A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT01696279

P6099clinical trial phasephase II clinical trialQ42824440
P17countryHungaryQ28
PolandQ36
TurkeyQ43
GermanyQ183
RomaniaQ218
ChileQ298
ArgentinaQ414
P582end time2018-11-16
P4135maximum age17
P1050medical conditionhyperphosphatemiaQ1641062
P2899minimum age10
P1132number of participants63
P4844research interventioncalcium carbonateQ23767
calcium oxalateQ412399
P6153research siteHannover Medical SchoolQ911561
P580start time2013-03-23
P8363study typeinterventional studyQ78089383
P1476titleA 3-part Open-label Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Compare the Efficacy, Safety and Tolerability of 8 Weeks of Treatment With Lanthanum Carbonate and Calcium Carbonate Using a Crossover Design and Investigate the Efficacy and Safety of 8 Months of Treatment With Lanthanum Carbonate in Hyperphosphataemic Children and Adolescents Aged 10 Years to <18 Years With Chronic Kidney Disease on Dialysis